JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 38 No. 5 797-802
© 1997 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borght, T. V.
Right arrow Articles by Kuhl, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borght, T. V.
Right arrow Articles by Kuhl, D. E.

Cerebral Metabolic Difference s in Parkinson's and Alzheimer's Disease s Matched for Dementia Severity

Thierry Vander Borght, Satoshi Minoshima, Bruno Giordani, Norman L. Foster, Kirk A. Frey, Stanley Berent, Roger L. Albin, Robert A. Koeppe and David E. Kuhl

Division of Nuclear Medicine and Departments of Internal Medicine, Psychiatry and Neurology, University of Michigan Medical School, and Geriatrics Research, Education and Clinical Center, Department of Veterans' Affairs Medical Center, Ann Arbor, Michigan

Correspondence: For correspondence or reprints contact: Satoshi Minoshima, MD, PhD, Division of Nucleer Medicine, Department of Internal Medicine, The University of Michigan Medical Center, B1G412 University Hospital, Ann Arbor, MI 48109-0028.

ABSTRACT

Despite controversial clinicopathological distinctions between Parkinson's disease with dementia (PDD) and Alzheimer's disease(AD), similar patterns of metabolic reduction in the posterior brain were reported previously using PET with [18F]fluorodeoxyglucose. The current study was designed to examine more specific regional differences in cerebral glucose metabolism between PDD and AD using accurate and objective brain mapping techniques. Methods: This study included nine normal subjects, nine PDD patients and nine AD patients. PDD and AD groups were matched carefully for age, sex and general dementia severity as measured by Mini-Mental State Examination and Clinical Dementia Rating scales. Each subject underwent [18F]fluorodeoxyglucose-PET and neuropsychological testing. After anatomic standardization of PET image sets and stereotactic data extraction, absolute and normalized cerebral metabolic rates were assessed by region of interest and pixel-by-pixel analyses. Results: PDD and AD showed global glucose metabolic reduction with similar regional accentuation involving the lateral parietal, lateral temporal and lateral frontal association cortices and posterior cingulate cortex in comparison to normal controls. When comparing between PDD and AD, however, PDD showed greater metabolic reduction in the visual cortex and relatively preserved metabolism in the medial temporal cortex. Conclusion: Although a common feature of metabolic abnormalities in the posterior brain exists in PDD and AD, the presence of regional metabolic differences suggests different degrees and combinations of disease specffic underlying pathological and neurochemical processes.

Key Words: Lewy body disease • Parkinson's disease • Aizheimer's disease • emission computed tomography • fluorine-18-FDG




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
M. S Parihar and G. J. Brewer
Mitoenergetic failure in Alzheimer disease
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C8 - C23.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
G. W. Small
Diagnostic Issues in Dementia: Neuroimaging as a Surrogate Marker of Disease
J Geriatr Psychiatry Neurol, September 1, 2006; 19(3): 180 - 185.
[Abstract] [PDF]


Home page
NeurologyHome page
M. L. Fantini, L. Ferini-Strambi, and J. Montplaisir
Idiopathic REM sleep behavior disorder: Toward a better nosologic definition
Neurology, March 8, 2005; 64(5): 780 - 786.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
F. J. Bonte, T. S. Harris, C. A. Roney, and L. S. Hynan
Differential Diagnosis Between Alzheimer's and Frontotemporal Disease by the Posterior Cingulate Sign
J. Nucl. Med., May 1, 2004; 45(5): 771 - 774.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. Ito, A. Nagano-Saito, T. Kato, Y. Arahata, A. Nakamura, Y. Kawasumi, K. Hatano, Y. Abe, T. Yamada, T. Kachi, et al.
Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study
Brain, June 1, 2002; 125(6): 1358 - 1365.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K Meguro, C LeMestric, B Landeau, B Desgranges, F Eustache, and J-C Baron
Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study
J. Neurol. Neurosurg. Psychiatry, September 1, 2001; 71(3): 315 - 321.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Lobotesis, J.D. Fenwick, A. Phipps, A. Ryman, A. Swann, C. Ballard, I.G. McKeith, and J.T. O'Brien
Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD
Neurology, March 13, 2001; 56(5): 643 - 649.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. J. Cross, S. Minoshima, S. Nishimura, A. Noda, H. Tsukada, and D. E. Kuhl
Three-Dimensional Stereotactic Surface Projection Analysis of Macaque Brain PET: Development and Initial Applications
J. Nucl. Med., November 1, 2000; 41(11): 1879 - 1887.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
G. Fenelon, F. Mahieux, R. Huon, and M. Ziegler
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Brain, April 1, 2000; 123(4): 733 - 745.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
E. Mori, T. Shimomura, M. Fujimori, N. Hirono, T. Imamura, M. Hashimoto, S. Tanimukai, H. Kazui, and T. Hanihara
Visuoperceptual Impairment in Dementia With Lewy Bodies
Arch Neurol, April 1, 2000; 57(4): 489 - 493.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. T. M. Hu, S. D. Taylor-Robinson, K. R. Chaudhuri, J. D. Bell, C. Labbe, V. J. Cunningham, M. J. Koepp, A. Hammers, R. G. Morris, N. Turjanski, et al.
Cortical dysfunction in non-demented Parkinson's disease patients: A combined 31P-MRS and 18FDG-PET study
Brain, February 1, 2000; 123(2): 340 - 352.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M T M Hu, S D Taylor-Robinson, K R. Chaudhuri, J D Bell, R G Morris, C Clough, D J Brooks, and N Turjanski
Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study
J. Neurol. Neurosurg. Psychiatry, July 1, 1999; 67(1): 20 - 26.
[Abstract] [Full Text]


Home page
NeurologyHome page
K. Ishii, S. Yamaji, H. Kitagaki, T. Imamura, N. Hirono, and E. Mori
Regional cerebral blood flow difference between dementia with Lewy bodies and AD
Neurology, July 1, 1999; 53(2): 413 - 413.
[Abstract] [Full Text]


Home page
NeurologyHome page
N. I. Bohnen, S. Minoshima, B. Giordani, K. A. Frey, and D. E. Kuhl
Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia
Neurology, February 1, 1999; 52(3): 541 - 541.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
T. Shimomura, E. Mori, H. Yamashita, T. Imamura, N. Hirono, M. Hashimoto, S. Tanimukai, H. Kazui, and T. Hanihara
Cognitive Loss in Dementia With Lewy Bodies and Alzheimer Disease
Arch Neurol, December 1, 1998; 55(12): 1547 - 1552.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Gilman
Imaging the Brain- Second of Two Parts
N. Engl. J. Med., March 26, 1998; 338(13): 889 - 896.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1997 by the Society of Nuclear Medicine.